April 12, 2022
US pharma giant Gilead Sciences has formally opened a centre of excellence in Dublin focusing on the development of medicines for children.
The office, based on the city’s North Dock, will oversee the development of new paediatric versions of its portfolio of medicines.
Gilead said it plans to expand the remit of the new Dublin operation to include work on clinical trials for adult therapies in development by the US group. It will also be home to part of an artificial intelligence team Gilead is recruiting.
“Gilead’s therapies address some of the world’s most challenging viral diseases, including HIV, viral hepatitis and Covid-19,” said Gilead chief executive and chairman Daniel O’Day, who was in Dublin for the event.
“Our Dublin teams play a critical role in adapting these therapies to treat children.”
Find out more here.